Koji Nagai

5PUBLICATIONS
39CO-AUTHORS
Clinical pharmacology and therapeuticsMetabolic medicineRheumatology and arthritisPredictive and prognostic markers
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (5)

|Apr 01, 2026
Clinical outcomes of molecular-targeted therapies for rheumatoid arthritis: comparison between orthopaedic surgeons and rheumatologists in the multicenter retrospective ANSWER cohort.

Yuki Etani, Yasutaka Okita, Kohei Tsujimoto

|Jul 01, 2025
Differential Impact of Concomitant Methotrexate and Glucocorticoids Dosages on Biologics and JAK Inhibitors: The ANSWER Cohort Study.

Kosuke Ebina, Yuki Etani, Yasutaka Okita

|Aug 19, 2023
Drug retention of biologics and Janus kinase inhibitors in patients with rheumatoid arthritis: the ANSWER cohort study.

Kosuke Ebina, Yuki Etani, Yuichi Maeda

|Mar 13, 2020
Drug retention of secondary biologics or JAK inhibitors after tocilizumab or abatacept failure as first biologics in patients with rheumatoid arthritis -the ANSWER cohort study.

Kosuke Ebina, Toru Hirano, Yuichi Maeda

|Oct 18, 2019
The family history of rheumatoid arthritis in anti-cyclic citrullinated peptide antibody-positive patient is not a predictor of poor clinical presentation and treatment response with modern classification criteria and treatment strategy: the ANSWER cohort study.

Koichi Murata, Motomu Hashimoto, Wataru Yamamoto

Pageof 1

Frequent Collaborators

5 joint publications

Koichi Murata

5 joint publications

Motomu Hashimoto

5 joint publications

Wataru Yamamoto

5 joint publications

Yonsu Son